Physician profile
Benjamin Bryan Goldenberg
NPI 1124522537
$866.89
in general payments reported to CMS, 2019-2025
11 companies · $354 in 2025
The $354 reported for 2025 was more than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $165 · 2024: $349 · 2025: $354.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $867.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $866.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $199.11 | 2023-2025 | Dovato, Cabenuva, Rukobia |
| Organogenesis INC. | $181.06 | 2023-2025 | Affinity, Puraply Wound Matrix, Novachor |
| Abbvie INC. | $154.63 | 2023-2025 | |
| Paratek Pharmaceuticals, INC. | $99.21 | 2023-2025 | Nuzyra |
| Urgo Medical North America, LLC | $92.77 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Convatec INC. | $37.78 | 2025 | |
| Polynovo North America LLC | $23.17 | 2024 | Novosorb Btm |
| Smith+Nephew, INC. | $21.66 | 2024 | Collagenase Santyl |
| Insmed, INC. | $21.33 | 2025 | Brinsupri, Arikayce |
| Mimedx Group, INC. | $20.88 | 2025 | |
| Reprise Biomedical, INC. | $15.29 | 2024 | Miro3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Goldenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.